Avalon GloboCare Corp. (ALBT): Nasdaq/NYSE listing notice — Avalon GloboCare receives Nasdaq delisting notice for negative stockholders' equity

Avalon GloboCare Corp.

Stockholders' equity of ($3,891,270) as of March 31, 2025, below Nasdaq's $2.5M minimum.
Company must submit a compliance plan by July 7, 2025; Nasdaq may grant extension to Nov 18, 2025.
Failure to regain compliance could lead to delisting, materially impacting liquidity and the pending YOOV merger.
Alternative compliance standards (market value of listed securities $35M or net income $500K) also not met.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Avalon GloboCare Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

May 22, 2025, Avalon GloboCare Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of ($3,891,270), as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, was below the required minimum of $2.5 million, and because, as of May 22, 2025, the Compa

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Avalon GloboCare Corp. filing history →

Source: SEC EDGAR

accession 0001213900-25-047391

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.